1.会议邀请函
尊敬的先生/女士，
细胞工程及抗体药物教育部工程研究中心和1929cc威尼斯联合主办的2016年生物药物创新及研发国际研讨会定于2016年10月14-15日在1929cc威尼斯召开。
研讨会将邀请生物药物领域的国内外知名专家学者、企业高管、技术精英等专业人士出席，共同探讨中国生物医药领域技术创新、新药研发、临床研究、产业化等论题，旨在提升中国生物医药产业的临床和创新力量，推动生物药物的研发和产业化发展。
热诚期待您的参与！
生物药物创新及研发国际研讨会组织委员会
大会主席：朱建伟
讲席教授，1929cc威尼斯
2.会议主题：生物药物创新及研发
Biopharmacutical Innovation and Development
3.会议时间：2016年10月14-15日
Date：14-15 October, 2016
会议地点：1929cc威尼斯闵行校区生物药学楼800号树华多功能厅
Venue：800 Dongchuan RD. 800 Shuhua Multi-functional Hall, Minhang District, Shanghai Jiao Tong University, Shanghai, China
4.主办单位：
细胞工程及抗体药物教育部工程研究中心
1929cc威尼斯
5.会议议程
14 October Morning Registration
14 October Afternoon Symposium
13:30 Welcome Speech
Jianwei Zhu Shanghai Jiao Tong University
Leader Shanghai Jiaotong University
13:40 Innovative Biologics in China: Opportunities and Challenges
Dechao Yu
Innovent Biologics (Suzhou) Co., Ltd.
14:20 Human monoclonal antibodies against cancer and viruses
Dimiter S. Dimitrov
National Cancer Institute, NIH
15:00 Tea Break（Poster Communication）
15:20 Developing next generation biologics therapies using FIT-Ig technology
Chenbing Wu
EpimAb Biotherapeutics Inc.
16:00 Novel Trimeric Biologics Targeting Cancer and Autoimmune Diseases
Peng Liang
Sichuan Clover Biopharmaceuticals, Inc.
16:40 Antibody Targeting of Extracellular Signaling Networks
Dawei Li
Shanghai Jiao Tong University
15 October Morning
08:30 The Local and Global Anatomy of Antibody-Protein Antigen Recognition
Buyong Ma
Frederick National Laboratory for Cancer Research
09:10 Self-forming nanoparticles as a new generation of vaccines
John Gilly
Leidos Biomedical Research, Inc. USA
09:50 Tea Break（Poster Communication）
10:10 A Novel Engineered VEGF Blocker with a Robust Anti-tumor Activity and Beyond
Xiangyang Zhu
10:50 Biologics Production: From Bench to Clinical Manufacturing
Xun Liu
Shanghai Hengrui Pharmaceutical Co., Ltd.
11:30 Therapeutic potential of targeting inflammatory cells in immune diseases
Feng Qian
Shanghai Jiao Tong University
12:10 Luncheon
14:00 Application of flow cytometry in the screening of monoclonal antibody drugs
and bioactivity validation
Hongliang Zong
Tofflon Science and Technology Co., Ltd.
14:40 Biopharmaceutical development of recombinant immunotoxins
Cedric Cagliero
Jecho Laboratories Inc. USA
15:20 Tea Break（Poster Communication）
15:40 TDM-1 ADC characterization with UPLC/MS and UNIFI
Lankun Song
16:20 Big effort on Medium matter toward biopharmaceutical development
Jinyou Zhang
BeiGene
17:00 Technology Innovation in Biopharmaceutical Development
Jianwei Zhu
Shanghai Jiao Tong University
17:40 Thanks Speech
